Provided by Tiger Trade Technology Pte. Ltd.

Vor Biopharma Inc.

22.71
-0.6500-2.78%
Post-market: 22.710.00000.00%19:30 EDT
Volume:500.00K
Turnover:11.31M
Market Cap:1.34B
PE:1.97
High:23.18
Open:23.12
Low:21.90
Close:23.36
52wk High:50.20
52wk Low:6.50
Shares:59.16M
Float Shares:37.23M
Volume Ratio:0.61
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):11.53
EPS(LYR):-70.5015
ROE:-125.43%
ROA:-21.37%
PB:-6.71
PE(LYR):-0.32

Loading ...

BRIEF-Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 02

Vor Biopharma initial beneficial ownership filed by TCG Crossover GP II, LLC

Reuters
·
Apr 02

Vor Bio grants inducement equity awards to 9 new hires under Nasdaq rule

Reuters
·
Apr 02

Vor Biopharma Is Maintained at Neutral by Wedbush

Dow Jones
·
Mar 31

Vor Bio price target raised to $15 from $9 at Wedbush

TIPRANKS
·
Mar 31

Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook

TIPRANKS
·
Mar 30

Vor Biopharma Q4 Adj. EPS $(1.63) Beats $(1.64) Estimate

Benzinga Earnings
·
Mar 30

Vor Biopharma Initiated at Buy by Jefferies

Dow Jones
·
Mar 30

Vor Biopharma Q4 profit tops estimates on warrant fair value gain

Reuters
·
Mar 30

Vor Bio Q4 FY25 net income climbs to $1.7B; pro-forma cash rises to $530M

Reuters
·
Mar 30

Vor Bio doses first patient in Phase 3 telitacicept Sjögren’s disease trial

Reuters
·
Mar 30

Rpt-Vor Biopharma Q4 Net Income USD 1,722.8 Million VS. Ibes Estimate USD -28.9 Million

THOMSON REUTERS
·
Mar 30

Vor Bio Doses First Patient in Global Phase 3 Upstream Sjd Registrational Trial of Telitacicept in Primary SjÖGren’s Disease

THOMSON REUTERS
·
Mar 30

Jefferies Initiates Vor Biopharma at Buy With $50 Price Target

MT Newswires Live
·
Mar 30

Vor Biopharma Inc : Jefferies Initiates Coverage With Buy Rating; Target Price $50

THOMSON REUTERS
·
Mar 30

Vor Bio initiated with a Buy at Jefferies

TIPRANKS
·
Mar 30

Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating

TIPRANKS
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

Vor Biopharma Shares Rise 1.5% After $75 Million Private Placement

THOMSON REUTERS
·
Mar 27

Vor Biopharma Announces $75 Million Private Placement

MT Newswires Live
·
Mar 27